RT @_bunnech: This was a fantastic collaboration between researchers at @EPFL, the @EPFL_AI_Center, the @Unispital_USZ, and @UZH_en with co….

RT @ISBSIB: “The paper is a step forward in terms of understanding the heterogeneous response of different cell states to environmental per….

RT @_bunnech: Super excited that our work #CellOT was selected among SIB's Remarkable Outputs 2023🎉: Curious about how we can predict singl….

RT @bioprotocolbyte: Happy #FluorescenceFriday ✨ .#Multiplexed protein measurements from multiple spatial scales using fluorescence #micros….

RT @yougotkunal: @joanapetrescu and I are excited to share our work repurposing @illumina HiSeq 2500s to automate highly multiplexed immuno….

RT @_bunnech: Check out our work on predicting #singlecell perturbation responses using neural optimal transport (#CellOT), which we presen….

Massive congratulations to the @pelkmanslab TP team & the whole #TumorProfiler Consortium on pushing #precisiononcology forwards for #melanoma #ovariancancer & #aml patients. Brilliant to see #4i drug response profiling used in a tumour board setting.

RT @N_Rajewsky: Neue Therapien : Visionäres Projekt in Berlin: Eine Klinik für zellbasierte Medizin

RT @venturelab_ch: Today's startup funding news: @Novartis joins forces with @MolecularPrtnrs, @4iLabs wins CHF 150'000, analysis of invest….

4iLabs wins the final stage of Venture Kick. Thrilled to have made the cut!. One step closer to revolutionising the therapy decision-making process for patients with progressed cancers. Thanks to @UZH_en, @BRIDGE_funding for supporting us from the start!.